CSL Malaysia Aleviate Human Coagulation Factor VIII 500IU/von Willebrand factor 1200IU complex, Powder for injection (50 IU/mL F

País: Australia

Idioma: inglés

Fuente: Department of Health (Therapeutic Goods Administration)

Ingredientes activos:

Von willebrand factor, Quantity: 1200 IU; Factor VIII, Quantity: 500 IU

Disponible desde:

CSL Behring Australia Pty Ltd

Designación común internacional (DCI):

Factor VIII,Von willebrand factor

formulario farmacéutico:

Injection, diluent for

Composición:

Excipient Ingredients: water for injections

Vía de administración:

Intravenous

Unidades en paquete:

500 IU FVIII/1200 IU VWF

tipo de receta:

(S1) This Schedule is intentionally blank

indicaciones terapéuticas:

Aleviate is indicated for: ? the prophylaxis and treatment of non-surgical and surgical bleeding in patients with von Willebrand disease when desmopressin (DDAVP) treatment is ineffective or contraindicated. ? the prophylaxis and treatment of non-surgical and surgical bleeding associated with FVIII deficiency due to haemophilia A.

Resumen del producto:

Visual Identification: Clear colourless solution free from visible particles.; Container Life Time: 3 Years; Container Temperature: Store at 2 to 8 degrees Celsius

Estado de Autorización:

Listed (Export Only)

Fecha de autorización:

2014-12-16